Vericel Corporation

Organisation

64 Sidney Street, Cambridge, MA, United States, 02139

Headquarters

Employees

Health Technology

Industry

Dominick Colangelo

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Price

Target

Vericel Corporation (VCEL) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Vericel Corporation (VCEL) share price will touch around $55.43 in next 12-months.

Currently 12 wall-street analysts regularly analyze the financials of Vericel Corporation on a frequent basis to provide recommendations along with target share price. 12 analysts offering 12-month price forecasts for Vericel Corporation (VCEL) have a share price target of $55.43. This median of share price forecast represents a 76.19% upside from the latest price of $31.46 as on 22.03.26.

Vericel Corporation (VCEL) Share Price Forecast

Home

US Stocks

Vericel Corporation (VCEL)

Vericel Corporation Stock Forecast

Vericel Corporation Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Vericel Corporation (VCEL): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Vericel Corporation's share price and its median forecast price. As on 22.03.26, the difference is -29.42%

Vericel Corporation Forecast and Target Price

Vericel Corporation (VCEL) Share Price Forecast

Vericel Corporation (VCEL) Price vs Consensus Price Target

Vericel Corporation (VCEL) Share Price Forecast v/s Share Price Today

Vericel Corporation (VCEL): Difference between Current Price & Median Forecasted Price

Vericel Corporation (VCEL) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price